ALNEV — Neovacs SA Share News
0.000.00%
Last trade - 00:00- €0.01m
- -€0.03m
- €0.16m
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants
Brief: Neovacs Announces EUR 0.5 Mln Fundraising Through OCEANE-BSA
Brief: Neovacs Progresses Towards Trial Stage For Lupus Treatment
Brief: Neovacs: Commits To Project To Transform Pharnext's Legal Structure
Brief: Neovacs Announces EUR 1 Mln Fundraising Through OCEANE-BSA Issue
Brief: Pharnext Gets Extra Funding From Neovacs, Appoints Hugo Brugiere As Chairman And CEO
Brief: Pharnext H1 Operating Loss Widens To EUR 13.2 Mln
Brief: Neovacs: Filing Of New International Patent Application For mRNA Technology In Allergies
Brief: Pharnext: Financing Agreement With Néovacs For EUR 20.7 Mln Net To Further Develop PXT3003
Brief: Pharnext Announces EUR 2.5 Mln Loan Agreement With Neovacs
Brief: Neovacs Raises EUR 2 Mln Through OCEANE-BSA Bonds Drawdown
Brief: Neovacs Completes Reimbursement Of Liabilities As Part Of Continuation Plan
Brief: Neovacs To Raise EUR 1 Mln Via OCEANE-BSA Bonds Drawdown
Brief: Neovacs Raises EUR 2 Mln Through OCEANE-BSA Bonds Drawdown
Brief: Neovacs Signs Agreement Allowing For Resumption Of Clinical Trials In China
Brief: Neovacs Invests In Medical Devices Venture